Table 2. Extended clinical follow-up of... | American Society of Hematology

Table 2.

Extended clinical follow-up of HIVnp

	Before biopsy (y)			Biopsy
Subjects	CD4, cells/mm³	VL, copies/mL	CD4, cells/mm³	VL, copies/mL	CD4, cells/mm³	VL, copies/mL
HIVnp 1	770 (2)*	500 (2)	410	4300	510 (1)*	1400 (1)
HIVnp 2	880 (3)	499 (3)	510	300	772 (3)	6300 (3)
HIVnp 3	1050 (1)	< 50 (1)	760	< 50	1179 (4)	< 50 (4)
HIVnp 4	600 (2)	200 (2)	920	< 50	N/A†	N/A†
HIVnp 5	820 (2)	< 50	620	200	739 (5)	200 (5)

	Before biopsy (y)			Biopsy
Subjects	CD4, cells/mm³	VL, copies/mL	CD4, cells/mm³	VL, copies/mL	CD4, cells/mm³	VL, copies/mL
HIVnp 1	770 (2)*	500 (2)	410	4300	510 (1)*	1400 (1)
HIVnp 2	880 (3)	499 (3)	510	300	772 (3)	6300 (3)
HIVnp 3	1050 (1)	< 50 (1)	760	< 50	1179 (4)	< 50 (4)
HIVnp 4	600 (2)	200 (2)	920	< 50	N/A†	N/A†
HIVnp 5	820 (2)	< 50	620	200	739 (5)	200 (5)

Number of years before or after biopsy when data were collected.

†

N/A indicates not available. This individual was put on highly active antiretroviral therapy (HAART) shortly after the biopsy was obtained, because she became pregnant. She did not have further follow-up.

View Large

This Feature Is Available To Subscribers Only